1月18日 的 Multiple Myeloma Management 應用程式分析
Multiple Myeloma Management
- UMA MLG, LLC
- Apple App Store
- 免費版
- 醫療
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
商店排名
商店排名基於Google和Apple設定的多個參數。
所有類別 在
美國--
醫療 在
美國--
![Multiple Myeloma [MM]](https://is1-ssl.mzstatic.com/image/thumb/Purple221/v4/dc/6e/02/dc6e0221-54cd-776e-d0f9-cdddc953da3f/AppIcon-0-0-1x_U007epad-0-11-0-85-220.png/175x175bb.jpg){kind=small}
Multiple Myeloma Management VS. 1月 18, 2026